List Title | APhA DrugInfoLine

Focus on Immunizations

SORT BY: Most Recent Most Viewed

May 20, 2013

Initiation of anti-TNF inhibitor does not increase herpes zoster risk

READ

PREVIEW
Individuals with rheumatoid arthritis (RA) and other inflammatory diseases who initiated anti-tumor necrosis factor (anti-TNF) therapy were not at greater risk of herpes zoster infection than...
March 10, 2013

Almost half of U.S. kids undervaccinated; alternate immunization schedules not yet warranted

READ

PREVIEW
An analysis of immunization records for nearly 320,000 children born between 2004 and 2008 revealed that 48.7% of children were undervaccinated in their first 24 months of life, with...
January 29, 2013

Updated recommendations for pneumococcal, tetanus, and influenza immunizations

READ

PREVIEW
Updates to the 2013 Advisory Committee on Immunization Practices (ACIP) Adult Immunization Schedule included first-time recommendations for use of the 13-valent pneumococcal conjugate vaccine (...
December 28, 2012

Shingles vaccine: Is a booster shot on the horizon?

READ

PREVIEW
In a follow-up of a 4-year herpes zoster vaccine live (Zostavax—Merck) trial conducted in a cohort of patients monitored for an additional 3 years, zoster vaccine efficacy decreased over time,...
November 6, 2012

Many health care personnel, pregnant women do not receive influenza vaccine

READ

PREVIEW
Approximately two-thirds of health care personnel and nearly half of pregnant women respondents reported receiving the influenza vaccine in 2011–12, according to two recent CDC Internet panel...

Pages

Medication Monitor

RSS Follow Medication Monitor on Twitter Follow APhA Druginfoline on Twitter

2215 Constitution Avenue NW, Washington, DC 20037 Telephone 202-628-4410 Fax 202-783-2351

© 2013 American Pharmacists Association All Rights Reserved.

About the American
Pharmacists Association

The American Pharmacists Association (APhA) is the organization whose members are recognized in society as essential in all patient care settings for optimal medication use that improves health, wellness and quality of life. Through information, education and advocacy, APhA empowers its members to improve medication use and advance patient care.

About APhA DrugInfoLine

APhA DrugInfoLine (ISSN 2162-3015) is a weekly publication of, and is owned and copyrighted by the American Pharmacists Association, the national professional society of pharmacists. Materials in APhA DrugInfoLine do not neccessarily represent the policy, recommendations, or endorsement of APhA. The publisher, authors, editors, reviewers, and contributors have taken care to ensure that the information contained in APhA DrugInfoLine is accurate and current; however, they shall have no ability to any person or entity with regard to claims, losses, or damage caused or alleged to be caused, directly or indirectly by use of any information contained in the publication. All decisions about drug therapy must be based on independent judgement of the clinician.